Basilea Pharmaceutica AG Capital Reinvestment Ratio
Basilea Pharmaceutica AG capital reinvestment ratio. Basilea Pharmaceutica AG (BSLN) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (CHF39.03 Million) in capital expenditures (CHF2.30 Million). Check how aggressively does Basilea Pharmaceutica AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Basilea Pharmaceutica AG (2005–2025)
Capital reinvestment ratio of Basilea Pharmaceutica AG from 2005 to 2025. This chart tracks Basilea Pharmaceutica AG's Capital Reinvestment Ratio across 8 annual periods. Also explore Basilea Pharmaceutica AG (BSLN) equity growth momentum to track the company's year-over-year net asset growth rate.
Basilea Pharmaceutica AG Capital Reinvestment Ratio by Year (2005–2025)
Basilea Pharmaceutica AG capital reinvestment ratio by year from 2005 to 2025. For the full cash flow conversion analysis, see Basilea Pharmaceutica AG cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CHF62.09 Million | CHF2.62 Million | ▲ +83.5% |
| 2024 | 0.02x | CHF74.36 Million | CHF1.71 Million | ▼ -68.3% |
| 2023 | 0.07x | CHF14.24 Million | CHF1.03 Million | ▼ -84.5% |
| 2022 | 0.47x | CHF7.06 Million | CHF3.30 Million | ▲ +1151.9% |
| 2017 | 0.04x | CHF19.01 Million | CHF711.00K | ▲ +319.3% |
| 2012 | 0.01x | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF34.38 Million | CHF1.20 Million | — |